Real-world treatment utilization in adults with chronic inflammatory demyelinating polyneuropathy in the United States

20260 citationsJournal Articlegold Open Access

Authors

C. Blein · Argenx (Belgium)

Chafic Karam · University of Pennsylvania

C Arvin-Berod · Argenx (Belgium)

Deborah E. Gelinas · Argenx (Belgium)

Sergio Barrera-Sierra Barrera-Sierra · Argenx (Belgium)

Hashmath Ulla Syed

Charlotte E. Ward

Amit Goyal

Abstract

Steroids and Ig were mainstay treatments among patients with CIDP. A substantial proportion of Ig users were chronic users who also received other CIDP therapies, with steroids being most common. This suggests a potentially pronounced burden among patients treated with frequent Ig and steroids.

Topics & Keywords

Peripheral Neuropathies and Disorders Hereditary Neurological Disorders Multiple Sclerosis Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Frontiers in Neurology

Volume 16, pp. 1726857-1726857

DOI: 10.3389/fneur.2025.1726857

Field-Weighted Citation Impact: 0.00